Want to see JP:3636 full AI Analyst Report?
3636 Stock Chart & Stats
¥4860.00
-¥5.00(-0.10%)
At close: 4:00 PM EST
¥4860.00
-¥5.00(-0.10%)
Day’s Range― - ―
52-Week Range¥4,375.00 - ¥5,360.00
Previous CloseN/A
Volume35.50K
Average Volume (3M)33.48K
Market Cap
¥76.71B
Enterprise Value¥38.21B
Total Cash (Recent Filing)¥41.91B
Total Debt (Recent Filing)¥982.00M
Price to Earnings (P/E)9.1
Beta0.70
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.44%
Share Statistics
EPS (TTM)525.61
Shares Outstanding16,044,000
10 Day Avg. Volume24,160
30 Day Avg. Volume33,480
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio29.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)435.05
Revenue Forecast (FY)¥131.12B
Bulls Say, Bears Say
Bulls Say
Improving ProfitabilityRevenue growth combined with improving gross margin and positive EBIT and EBITDA margin trends indicates effective cost management and strengthening operating efficiency. These qualities support more durable profitability across MRI’s research, consulting, and systems-integration activities.
Very Conservative Balance SheetMinimal leverage and a strong equity base provide substantial financial stability. MRI should have greater flexibility to fund projects, maintain operations, and absorb business volatility without the interest burden or refinancing pressure associated with a heavily indebted balance sheet.
Healthy Operating Cash GenerationHealthy operating cash flow and a stable relationship between cash flow and net income indicate that reported earnings are supported by ongoing cash generation. This gives MRI a sound base for operating needs and continued investment in service capabilities.
Bears Say
Declining Free-cash-flow GrowthSlower free-cash-flow growth and weaker conversion of net income into free cash flow could reduce the funds available for future investments, shareholder returns, or strategic initiatives. If sustained, this may constrain MRI’s ability to translate profitability into financial flexibility.
Slightly Lower Return On EquityA modest decline in return on equity suggests MRI is generating somewhat less profit from its shareholders’ capital than previously. Even with a strong equity base, weaker capital productivity can limit earnings efficiency and reduce the benefit of balance-sheet strength.
Moderate Latest Revenue GrowthThe latest annual revenue increase is positive but moderate, and it follows a prior-year dip. This pattern indicates that growth has not been consistently strong, which could make it harder to expand earnings rapidly unless demand for consulting, public-sector programs, and digital solutions accelerates.
Mitsubishi Research Institute News
3636 FAQ
What was Mitsubishi Research Institute’s price range in the past 12 months?
Mitsubishi Research Institute lowest stock price was ¥4375.00 and its highest was ¥5360.00 in the past 12 months.
What is Mitsubishi Research Institute’s market cap?
Mitsubishi Research Institute’s market cap is ¥76.71B.
When is Mitsubishi Research Institute’s upcoming earnings report date?
Mitsubishi Research Institute’s upcoming earnings report date is Nov 04, 2026 which is in 28 days.
How were Mitsubishi Research Institute’s earnings last quarter?
Mitsubishi Research Institute released its earnings results on Jul 29, 2026. The company reported -¥100.96 earnings per share for the quarter.
Is Mitsubishi Research Institute overvalued?
According to Wall Street analysts Mitsubishi Research Institute’s price is currently Overvalued.
Does Mitsubishi Research Institute pay dividends?
Mitsubishi Research Institute pays a Semiannually dividend of ¥85 which represents an annual dividend yield of 3.44%. See more information on Mitsubishi Research Institute dividends here
What is Mitsubishi Research Institute’s EPS estimate?
Mitsubishi Research Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mitsubishi Research Institute have?
Mitsubishi Research Institute has 16,044,000 shares outstanding.
What happened to Mitsubishi Research Institute’s price movement after its last earnings report?
Mitsubishi Research Institute reported an EPS of -¥100.96 in its last earnings report. Following the earnings report the stock price went up 2.758%.
Which hedge fund is a major shareholder of Mitsubishi Research Institute?
Currently, no hedge funds are holding shares in JP:3636
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mitsubishi Research Institute
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financial organizations, and private corporations. The company's extensive solutions span areas such as management consultation, digital and financial innovation, environmental and energy initiatives, healthcare and wellness, regional development, future infrastructure deployment, scientific and safety research, nuclear safety, and broad economic, social, and R&D initiatives. Furthermore, MRI handles specialized project engagements and public sector procurement. In a key collaboration, it partners with ForePaaS SAS to implement cloud-native data-intensive solutions across Japan. Established in 1970, Mitsubishi Research Institute, Inc. is headquartered in Tokyo.